Predictive factors for recovery time in patients suffering from severe OHSS

نویسندگان

  • Kazem Nouri
  • Clemens B Tempfer
  • Christian Lenart
  • Lisa Windischbauer
  • Katharina Walch
  • Regina Promberger
  • Johannes Ott
چکیده

BACKGROUND To evaluate predictive factors for recovery time from severe ovarian hyperstimulation syndrome (OHSS). METHODS In a retrospective cohort study, 201 women who were hospitalized for severe OHSS were included. Patients with recurrent OHSS were excluded. All the patients received standardized treatment including intravenous hydration, plasma volume expansion, human albumin, furosemid, subcutaneous heparin, and paracentesis if necessary. The main outcome parameter was recovery time from OHSS. Recovery was defined if a morning hematocrit <40%, rebalance of electrolytes, and serum creatinine <1 mg/dL were reached during the standardized therapy and the patient had not suffered from abdominal pain and discomfort at least for one day without any OHSS-specific infusions or medications. RESULTS Pregnant patients (n=80, 39.8%) revealed a longer median duration until recovery than non-pregnant patients (n=121, 60.2%; 10 days, IQR 7-13, vs. 8 days, IQR 6-10, respectively; p=0.001). In a generalized linear model, presence of polycystic ovary syndrome before controlled ovarian hyperstimulation (beta=0.3342 +/- 0.1335, p=0.012) and use of hCG for ovulation induction (beta=0.222 +/- 0.1389, p=0.048) were associated with a longer recovery time in pregnant patients. In non-pregnant patients, none of the tested factors was associated with recovery time. CONCLUSIONS Pregnant patients with severe OHSS needed a significantly longer recovery time than non-pregnant patients. In pregnant patients, presence of polycystic ovary syndrome and ovulation induction with hCG were associated with longer recovery times.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Onm-5: Evaluation of Patients with Ovarian Hyper Stimulation Syndrome and Medical Care in Infertility Treatment Course in Royan Research Center from 2010 to 2012

Background: Ovarian Hyper stimulation syndrome (OHSS) is infrequent and iatrogenic complication of ovary stimulation by Follicular stimulating hormone (FSH). OHSS is a probable complication of ovulation stimulating drugs, including clomiphene citrate and gonadotropins. Development of infertility treatment with the aim of reaching the desirable number of oocyte and embryo has led to ovary stimul...

متن کامل

I-26: The Role of Stimulating Agents and Protocols in Prevention of Severe OHSS

The goal of ovarian Stimulation for assisted reproductive technologies (ART) is obtaining multifollicular growth ovarian hyper stimulation syndrome (OHSS) is one of the most Severe and also potentially Life-threatening complications, which happens in 1-10% of IVF cycles. The most common risk factors which are related to OHSS are polycystic ovarian syndrome (PCOS), younger age, high preovulatory...

متن کامل

Onm-15: New Approaches in OHSS

Ovarian Hyper stimulation syndrome (OHSS) is one of the most serious and life threatening complication of ovulation induction and is a major concern and challenge for physicians involved in assisted reproductive technologies (ART). The main complication of OHSS is intravascular fluid and protein out flow into third space. Human chronic gonadotropin (hCG) increases vascular permeability by indir...

متن کامل

I-32: Prevention Protocols in Order to Prevent OHSS in COS of PCO and Non PCO Patients in ART Cycle

Background: The affordable protocol to prevent the severe OHSS in two groups of patients PCO syndrome and non PCO high responder. Methods and Materials: PubMed and Medline were searched from January 2000 till end of May 2014. This Study investigates whether the mild protocol is associated to prevent severe OHSS in infertile female. Results: According to this survey, 9 studies were included and ...

متن کامل

Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.

Vascular endothelial growth factor (VEGF) is stated to be a possible promoter of the development and the severity of ovarian hyperstimulation syndrome (OHSS). The secretion of VEGF in granulosa cells seems to be human chorionic gonadotrophin (HCG) dependent. In this prospective study, the data of 10 patients suffering from severe OHSS with ascites and pleural effusions (haematocrit, fluid balan...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 12  شماره 

صفحات  -

تاریخ انتشار 2014